aPTTlaboratory testused to see ifheparin iswithintherapeuticrangeRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XatranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.ThrombolyticDrugsagentsthatdissolveblood clotsIdarucizumabAntidotefordabigatranVitaminKantidoteforwarfarinHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.alteplaseprototypethrombolyticdrugdabigatranThe onlyoral directthrombininhibitorPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHemorrhagemajor sideeffect ofHeparintherapyDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.DVTand PEHeparin isgivenprophylacticallyto patients toprevent theseAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationThrombolysisDissolutionof bloodclotsProtamineSulfateAntidoteforheparin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerActionofwarfarinActs in theliver topreventsynthesis ofvitamin KClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.Heparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodieswarfarinPrototypevitamin KantagonistaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XatranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.ThrombolyticDrugsagentsthatdissolveblood clotsIdarucizumabAntidotefordabigatranVitaminKantidoteforwarfarinHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.alteplaseprototypethrombolyticdrugdabigatranThe onlyoral directthrombininhibitorPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHemorrhagemajor sideeffect ofHeparintherapyDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.DVTand PEHeparin isgivenprophylacticallyto patients toprevent theseAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationThrombolysisDissolutionof bloodclotsProtamineSulfateAntidoteforheparin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerActionofwarfarinActs in theliver topreventsynthesis ofvitamin KClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.Heparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodieswarfarinPrototypevitamin Kantagonist

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. laboratory test used to see if heparin is within therapeutic range
    aPTT
  2. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  3. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  4. agents that dissolve blood clots
    Thrombolytic Drugs
  5. Antidote for dabigatran
    Idarucizumab
  6. antidote for warfarin
    Vitamin K
  7. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  8. prototype thrombolytic drug
    alteplase
  9. The only oral direct thrombin inhibitor
    dabigatran
  10. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  11. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  12. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  13. major side effect of Heparin therapy
    Hemorrhage
  14. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  15. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  16. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  17. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  18. Dissolution of blood clots
    Thrombolysis
  19. Antidote for heparin
    Protamine Sulfate
  20. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  21. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  22. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  23. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  24. Prototype vitamin K antagonist
    warfarin